GRDNNYSERetail-Drug Stores and Proprietary StoresUS GAAP · USD

Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. is a U.S. institutional pharmacy services company focused on long-term care facilities. It contracts directly with LTCFs to dispense, package, track, and manage medications for residents, with a particular emphasis on assisted living and behavioral health facilities.

Liikevaihto1 449milj. USD
+17,9 %v/v
Liikevoitto (EBIT)72,7milj. USD
+215,5 %v/v
EBIT-marginaali5,0%
+10,1 %-yks.v/v
Nettotulos49,2milj. USD
+144,7 %v/v
Vapaa kassavirta100milj. USD

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2024–2025

−50005001 0001 500milj. USD2024: 1 228 milj. USD2024: EBIT −63 milj. USD20242025: 1 449 milj. USD2025: EBIT 73 milj. USD20251 44973
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Institutional pharmacy services70 %

Core dispensing, fulfillment, delivery, and billing services for LTCF residents.

Compliance packaging and medication management15 %

Unit-dose and multi-dose packaging plus tracking systems that support adherence.

Clinical and operational support services10 %

Training, audits, and care-support services that help facilities manage medication use.

Acquired and greenfield pharmacy operations5 %

Revenue from newly acquired pharmacies and start-up locations being integrated into the network.

Asiakkaat

Guardian sells primarily to long-term care facilities, which use it as the principal pharmacy provider for their residents. Its resident base is concentrated in assisted living facilities and behavioral health facilities, with additional exposure to skilled nursing and other LTCF settings. The company also serves local and multi-facility operators that want a specialized, high-touch pharmacy partner with compliance and clinical support.

Assisted living facilities (ALFs)

Buy pharmacy services, packaging, and clinical support to manage residents with growing medication needs.

Behavioral health facilities (BHFs)

Buy specialized dispensing and tracking services for residents with complex medication regimens.

Skilled nursing facilities (SNFs)

Buy institutional pharmacy services for higher-acuity residents and regulated care workflows.

Long-term care facility operators

Contract for pharmacy coverage across multiple facilities to standardize service and billing.

Residents of LTCFs

Indirect end users who receive the medications and adherence support delivered through the facilities.

Strategia

Guardian is expanding by increasing residents served through both organic growth and acquisitions of institutional pharmacies. Management is also extending the model beyond its core LTCF base into adjacent care settings such as IDD, hospice, and PACE, while continuing to invest in automation, data analytics, and local operating autonomy. The strategy is designed to deepen share in attractive LTCF subsegments and broaden the addressable market without losing the high-touch service model.

Organic resident growthLyhyt aikaväli

Adds volume at existing pharmacies and improves operating leverage without requiring a full acquisition.

Acquisitions of institutional pharmaciesKeskipitkä aikaväli

Accelerates scale, adds new facilities, and broadens geographic reach.

Adjacency expansionKeskipitkä aikaväli

Diversifies the business beyond core LTCFs and opens new growth markets.

Automation and analytics investmentKeskipitkä aikaväli

Supports service quality, efficiency, and differentiation versus local and national competitors.

Maantiede

Guardian operates across 38 U.S. states and serves a national network of LTCFs through local pharmacies. The business is geographically fragmented rather than concentrated in one state, which helps diversify facility-level exposure but requires local execution, licensing, and logistics. Its footprint matters because pharmacy service quality depends on proximity, state regulation, and relationships with local facility operators.

Riskit

Guardian faces competitive pressure from national, regional, and local pharmacies, which can compress margins and make customer retention harder. Its model also depends on accurate dispensing, reliable logistics, and proper caregiver administration at LTCFs, so errors or supply disruptions can create liability, reputational damage, and service interruptions. Because reimbursement and collections can be complex, payor disputes and credit losses are also important operating risks.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Dispensing, packaging, or labeling errors1Competitive pressure from national, regional, and local pharmacies2Supply chain and third-party logistics disruption3Caregiver administration failures at LTCFs4Credit and reimbursement collection risk5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Dispensing, packaging, or labeling errorsVaikutus: KriittinenTodennäköisyys: Kohtalainen

    The business handles pharmaceuticals directly, so mistakes can lead to serious injury, claims, and reputational harm.

    Kohdistuu: Prescription fulfillment and compliance packaging

  2. Competitive pressure from national, regional, and local pharmaciesVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Customers can switch providers if pricing, service, or relationships weaken, which can pressure margins and growth.

    KohdistuuALFsBHFsSNFsLocal markets
  3. Supply chain and third-party logistics disruptionVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Guardian relies on external warehousing and distribution for some pharmaceuticals, creating operational dependency.

    Kohdistuu: Pharmaceutical warehousing and delivery

  4. Caregiver administration failures at LTCFsVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Even if Guardian dispenses correctly, improper administration by facility staff can create adverse outcomes and liability.

    Kohdistuu: Resident medication administration

  5. Credit and reimbursement collection riskVaikutus: KeskitasoTodennäköisyys: Matala

    Facility and private-pay billing can be complex and disputed, increasing allowance needs and cash collection risk.

    Kohdistuu: Accounts receivable from facilities and payors

Kysy Clarifolta: Guardian Pharmacy Services, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition at point of delivery

Revenue is booked when prescriptions and services are delivered, so timing of facility activity affects quarterly revenue.

Vaikutus: Can create quarter-to-quarter volatility in reported sales

Allowance for credit losses

Facility and private-pay receivables can be disputed or delayed, requiring judgment on collectability.

Vaikutus: Affects net revenue, receivables, and cash flow

Acquisition accounting and integration

Recent acquisitions change the revenue base and can make year-over-year comparisons less clean.

Vaikutus: Impacts reported growth, margins, and goodwill/intangibles

Share-based compensation from IPO reorganization

The corporate reorganization created a large non-cash compensation charge.

Vaikutus: Distorts GAAP earnings and SG&A comparability

Intangible asset amortization

Acquired pharmacies create amortizable intangibles that reduce operating profit under GAAP.

Vaikutus: Pressures reported net income versus adjusted results

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026

Guardian Pharmacy Services, Inc. (GRDN) liikevaihto, tulos ja tunnusluvut 2025 – Clarifo